Dyadic International, Inc. ("Dyadic”, "we”, "us”, "our”, or the "Company”) (NASDAQ: DYAI), a biotechnology company specializing in the development of functional recombinant solutions and proprietary ...

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. And welcome to Invivyd’s First Quarter ...

This research roundup discusses researchers’ attempts to find a treatment for a “brain fog” that comes with CAR T-Cell ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies.

Scientists use cell culture to probe cellular function, drive chemical processes, and manufacture key agents for research, ...

A team of scientists has answered a long-standing question in cell biology, uncovering how the cell's main energy currency, ATP, is transported into the endoplasmic reticulum (ER). Disrupted energy ...

AbCellera’s ‘408 Patent is directed to microfluidic devices and using such devices to culture and selectively recover cells. Previously Berkeley Lights Inc., now Bruker Cellular Analysis ...

SEVEN YEARS AFTER HIS INITIAL CHEMOTHERAPY AND STEM CELL TRANSPLANT, IT CAME BACK. MYELOMA IS A DIFFICULT DISEASE TO FIGHT. IT SEEMS LIKE IT ALWAYS COMES BACK. IT’S NOT CURABLE AT THIS POINT.

(A) Overview of the seven-stage differentiation protocol performed in a 3D culture system. (B) Frequency of C-peptide (C-pep) and glucagon (GCG) positive cells in 5 cell lines (HUES8, RC9, LUMC ...